Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
This study will examine the potential for an Interactive Cancer Communication System (ICCS) to impact not only psychosocial outcomes such as quality of life but also length of survival in an advanced stage lung cancer population. Two hypotheses will be tested: the Comprehensive Health Enhancement Support System- Lung Cancer (CHESS- LC) will significantly improve patient quality of life and length of overall survival as compared to a usual care control group.
Checked against the public recordLast updated Nov 15, 2019 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Wisconsin, Madison
- Interventions being studied
- Other: CHESS website for lung cancer patient + internet access if needed
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * All patients must be diagnosed with non-small cell lung cancer (Stage IIIA non surgical, IIIB or IV) * All patients must be within 12 months of their primary lung cancer diagnosis or metastatic or recurrence disease. * All patients must be at least 18 years of age, * All patients must have an ECOG Performance Status rating of level 0, 1 or 2. * If patients have brain metastases, they must be stable * All patients must be under the care of a clinician who has consented to participate in the study. * All patients must be able to speak and read English (educational attainment of at least 6th grade). * All patients will be invited to have a caregiver also participate in the study, however this is not required.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Harry Gray Cancer Center at Hartford HospitalHartford, Connecticut
- University of Illinois at Chicago Cancer CenterChicago, Illinois
- M.D. Anderson Cancer CenterHouston, Texas
- University of Wisconsin Carbone Cancer CenterMadison, Wisconsin
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 15, 2019. Always confirm current availability with the study team.